The parameters governing pharma promotional speech in digital and social media have struggled to keep pace with the rapidly evolving healthcare communications landscape. How can FDA play catch-up in advancing an agenda more reflective of industry and patient needs?
Closing the Digital Gap: FDA’s Oversight of Social Media (pharmexec.com)
